Table 3 Meta-analysis of Case-control Studies on the Risk of Prostate Cancer Tissues and Sera, Stratified by Region, Publication Calendar Period and HPV Type.

From: Worldwide Prevalence of Human Papillomavirus and Relative Risk of Prostate Cancer: A Meta-analysis

 

Total

Tissue-based detection

Serum-based detection

No. of studies

No. of cases

P for heterogeneity

OR a (95% CI b)

No. of studies

No. of cases

P for heterogeneity

OR (95% CI)

No. of studies

No. of cases

P for heterogeneity

OR (95% CI)

Total

34

4540

<0.001

1.32 (1.12–1.55)

26

1218

<0.001

1.79 (1.29–2.49)

10

3436

0.302

1.03 (0.95–1.12)

Region

 North America

12

2543

0.883

1.01 (0.90–1.14)

6

225

0.632

0.98 (0.70–1.36)

6

2318

0.813

1.02 (0.90–1.15)

 Europe

8

1057

0.075

1.11 (0.93–1.32)

7

258

0.180

1.95 (1.35–2.81)

2

850

0.665

0.94 (0.79–1.13)

 Asia

8

473

0.162

2.82 (1.89–4.21)

8

473

0.162

2.82 (1.89–4.21)

0

0

NA

NA

 Africa

1

205

NAc

NA

0

0

NA

NA

1

205

NA

NA

 Latin America

3

161

0.119

5.76 (2.25–14.76)

3

161

0.119

5.76 (2.25–14.76)

0

0

NA

NA

 Ocean

2

101

0.008

1.29 (0.25–6.80)

2

101

0.008

1.29 (0.25–6.80)

0

0

NA

NA

 Mixed

0

0

NA

NA

0

0

NA

NA

1

63

NA

NA

Publication calendar period

 1990–1999

12

494

0.029

1.37 (0.85–2.21)

11

447

0.018

1.38 (0.82–2.30)

2

110

0.257

0.71 (0.20–2.50)

 2000–2015

22

4046

<0.001

1.34 (1.12–1.59)

15

771

0.036

2.13 (1.45–3.12)

8

3326

0.243

1.04 (0.96–1.12)

HPV Type

 High-riskd

24

3525

0.006

1.19 (1.00–1.42)

17

819

<0.001

1.70 (1.03–2.82)

9

2820

0.383

1.06 (0.96–1.16)

 Low-riske

5

331

0.534

0.75 (0.38–1.47)

5

331

0.534

0.75 (0.38–1.47)

1

51

NA

NA

Related to HPV16

 Yes

24

4090

0.018

1.15 (0.96–1.36)

16

768

0.001

1.95 (1.06–3.57)

10

3436

0.424

1.05(0.96–1.16)

 No

12

3157

0.283

1.10 (0.94–1.29)

8

409

0.066

1.75 (1.22–2.51)

5

2799

0.962

0.98 (0.84–1.16)

Related to HPV18

 Yes

12

3181

0.284

1.02 (0.82–1.28)

8

433

0.094

1.82 (0.97–3.41)

5

2799

0.606

0.92 (0.73–1.17)

 No

16

3318

0.149

1.08 (0.96–1.21)

12

570

0.054

1.60 (1.23–2.09)

5

2799

0.895

0.98 (0.87–1.11)

  1. aOR: Odds ratio.
  2. b95% CI: 95% confidence interval.
  3. cNA: Not available.
  4. dHigh-risk: HPV 16, 18, 31, 33, 35, 39, 45, 52, 58, 59 and 68.
  5. eLow-risk: HPV 6 and 11.